Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of VALPROT 500XR vs Innovator in Healthy Volunteers
NCT05641649Phase 4Unknown
- Sponsor
- Kathmandu University
- Start
- Aug 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sodium valproate + valproic acid in epilepsy, sponsored by Kathmandu University. Status: unknown.
02
Drugs
Sodium valproate + valproic acid
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT05641649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05641649.